Dion Gisele 4
4 · Cytek Biosciences, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Dion Gisele
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-01+25,789→ 25,789 totalExercise: $9.67From: 2023-06-01Exp: 2032-06-01→ Common Stock (25,789 underlying)